Compare SLDB & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLDB | IBEX |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.6M | 489.1M |
| IPO Year | 2018 | 2020 |
| Metric | SLDB | IBEX |
|---|---|---|
| Price | $6.21 | $30.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $14.70 | ★ $31.33 |
| AVG Volume (30 Days) | ★ 1.1M | 185.3K |
| Earning Date | 03-05-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.47 |
| EPS | N/A | ★ 3.04 |
| Revenue | N/A | ★ $603,274,000.00 |
| Revenue This Year | N/A | $12.15 |
| Revenue Next Year | N/A | $5.68 |
| P/E Ratio | ★ N/A | $9.91 |
| Revenue Growth | N/A | ★ 15.63 |
| 52 Week Low | $2.41 | $21.64 |
| 52 Week High | $7.37 | $42.99 |
| Indicator | SLDB | IBEX |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 26.76 |
| Support Level | $6.01 | $28.97 |
| Resistance Level | $7.33 | $39.98 |
| Average True Range (ATR) | 0.44 | 2.26 |
| MACD | -0.06 | -0.76 |
| Stochastic Oscillator | 29.63 | 10.24 |
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.